Frontiers in Bioscience-Landmark (FBL) is an international peer-reviewed open access journal of cellular and molecular biology. FBL is dedicated to publishing advances in all aspects of cellular and molecular biology of eukaryotic and prokaryotic cells, including studies related to biochemistry, biophysics, physiology, pathology, biotechnology, bioinformatics, and other related fields. This journal is a member of the Committee on Publication Ethics (COPE).
Company Details
- Employees
- 2
- Founded
- -
- Address
- #05-02f, 50 Tagore Lane, Singapore,singapore 787494,singapore
- Industry
- Book And Periodical Publishing
- NAICS
-
Publishing Industries (except Internet)Newspaper, Periodical, Book, and Directory PublishersDirectory and Mailing List PublishersOther PublishersGreeting Card PublishersAll Other Publishers
- Keywords
- Cell Biology, Biochemistry and Molecular Biology, Biology, Cancer, Genetics, Basic Sciences.
- HQ
- Singapore, Singapore
Frontiers In Bioscience-Landmark Questions
Frontiers In Bioscience-Landmark's website is https://www.imrpress.com/journal/FBL
Frontiers In Bioscience-Landmark's LinkedIn profile is https://sg.linkedin.com/company/frontiers-in-bioscience-landmark
Frontiers In Bioscience-Landmark has
2 employees.
View email and phone details for 2
employees at Frontiers In Bioscience-Landmark.
Frontiers In Bioscience-Landmark's industry is
Book and Periodical Publishing
Frontiers In Bioscience-Landmark's top competitors are
Biologia Celular - Ufcspa,
Wavejo,
Wavejo Publishers,
Gainmed,
Elfomed Medi̇cal Aestheti̇c Agency,
Journal Of Experimental & Clinical Cancer Research,
Imr Press,
Rainbow Pharma Consulting,
Frontiers In Bioscience-Scholar,
Dibrain.
Frontiers In Bioscience-Landmark's categories are Book and Periodical Publishing
Frontiers In Bioscience-Landmark's founding year is 1996
